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Background: Tree bark of Eucommia ulmoides Oliv., (commonly well-known as “Du-zhong” in China), has been used
to treat hypertension, hypercholesterolemia, hyperglycemia, hepatic fibrosis and renal injury. This study aims to
investigate the effects of lignans extracted from the bark of Eucommia ulmoides Oliv. on Ang II-induced proliferation
and extracellular matrix biosynthesis in rat mesangial cells.
Methods: Rat mesangial cells (RMCs) were cultured in vitro and divided into six groups (control, Ang II, losartan,
and low, middle and high concentration lignans groups). RMC proliferation was measured by MTT assay. RT-qPCR
and western blotting were used to detect mRNA and protein expression of collagen type I (Col I), collagen type III
(Col III), collagen type IV (Col IV), fibronectin and aldose reductase (AR).
Results: Cellular proliferation induced by Ang II was significantly suppressed by Eucommia lignans of different
concentrations (P = 0.034, P < 0.001, and P < 0.001). Treatment of cells with Ang II increased Col I, Col III, Col IV, and
fibronectin mRNA expression, which was observed at the protein level (P < 0.001, P < 0.001, P = 0.004, and P = 0.004,
respectively). The increased mRNA expression and protein levels of Col I, Col III, Col IV, and fibronectin were
diminished remarkably with by treatment Eucommia lignans, and elevated AR expression stimulated by Ang II was
significantly inhibited by Eucommia lignans.
Conclusions: Eucommia lignans (Du-zhong) inhibited Ang II-stimulated extracellular matrix biosynthesis in
mesangial cells.Background
Hypertension is the second leading cause of end-stage
renal disease [1], resulting in hypertensive nephropathy,
which usually starts with glomerulosclerosis [2,3]. The
pathophysiologic process is associated with structural
changes to renal glomeruli due to mesangial cell (MC)
proliferation and abnormal accumulation of extracellular
matrix (ECM) [3,4]. Angiotensin II (Ang II), the main ef-
fective peptide in the rennin-angiotensin system (RAS) is
considered a key mediator in the development of hyperten-
sive glomerulosclerosis [3,5]. RAS regulates the prolifera-
tion of MCs and increases the production of ECM, mainly* Correspondence: ouyangyj@163.com
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reproduction in any medium, provided the orthrough the induction of glomerular hypertension, as
well as non-hemodynamic effects, which include the pro-
duction of reactive oxygen species, up-regulation of profi-
brotic growth factors, such as platelet-derived growth factor
(PDGF), transforming growth factor-β1 (TGF-β1), tumor
necrosis factor-α (TNF-α) and connective tissue growth
factor, and macrophage activation and infiltration [3,6-8].
Aldose reductase (AR), a member of the aldo-keto
reductase super family, catalyzes the conversion of glu-
cose to sorbitol dependent on NADPH in the first step of
the polyol pathway [9]. AR can be activated by TGF-β1,
oxidative stress and inflammation [9-12], to stimulate pro-
liferation of MCs and deposition of ECM induced by
TGF-β1 and PDGF [13-16]. An over-expression of AR
was observed in the renal tissue of spontaneous hyperten-
sive rats (SHR) in our previous study [12]. AR might behis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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in MCs.
Cortex Eucommiae (Du-zhong), the dried bark of the
Eucommia ulmoides Oliv. (Family: Eucommiaceae), has
been served as a traditional tonic medicine and is thought
to benefit the liver and kidney, strengthen tendons and
bones, and prevent miscarriage [17]. The natural products
that have been identified from Du-zhong include lignans,
iridoids, flavonoids, polysaccharides, terpenes and protein
[18], which possess various pharmacological effects, includ-
ing antihypertensive, antioxidant, antimicrobial, and anti-
inflammatory properties [9,18]. We previously confirmed
that lignans were the effective fraction of Du-zhong for
antihypertension [10,19]. Further study showed that both
N-acetyl-β-D-glucosaminidase enzyme activity and the
ratio of albumin to urinary creatinine decreased in spon-
taneous hypertensive rat (SHR)-treated with Eucommia
lignans [12]. Eucommia lignans also inhibited the expres-
sion of collagen type III (Col III) in the glomerular base-
ment membrane, and diminished the over-expression of
AR in the kidney [11]. Accordingly, we hypothesized that
lignans decreased the production of Col III by affecting
AR expression and thus decreased damage to the glom-
erular structure [12].
This study aims to investigate the effects of lignans
extracted from the bark of Eucommia ulmoides Oliv.
On Ang II-induced proliferation and extracellular matrix
biosynthesis in rat mesangial cells, and attempted to
elucidate the mechanisms by which Eucommia lignans




RPMI-1640 medium, newborn calf serum (NCS), RT-
qPCR kits with Platinum® SYBR® Green qPCR Super
Mix-UDG, and primers for collagen I (Col I), Col III,
collagen type IV (Col IV), fibronectin and AR were pur-
chased from Invitrogen (Carlsbad, CA, USA). Antibodies
for Col I, Col III, Col IV, fibronectin and AR for western
blotting were supplied by Abcam (Cambridge, England)
and Santa Cruz Biotechnology Inc. (CA, USA). The Cell
Titer 96® Aqueous One Solution Proliferation Assay for
the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazo-
lium bromide (MTT) method was provided by Promega
(Madison, WI, USA). A Revert Aid First Strand cDNA
Synthesis Kit was purchased from Thermo Scientific
(Austin, TX, USA). Losartan was obtained commercially
from the National Institute for Food and Drug Control
(Beijing, China). Human Angiotensin II and other analyt-
ical grade reagents were purchased from Sigma-Aldrich
(St. Louis, MO, USA).
Eucommia lignans were extracted at our own labora-
tory as described previously [12,19,20]. E. ulmoides wereobtained from Changsha Medical Company (Hunan,
China) in July 2009, and authenticated by Dr. Dong-Sheng
Ouyang, one of the authors according to the methods
described in the literature [21]. A voucher specimen
of Eucommia ulmoides Oliv. (IBSC_0345347) was de-
posited at South China Botanical Garden Herbarium,
Guangdong, China. Briefly, fresh Eucommia ulmoides
Oliv. bark was cut into pieces and extracted with 60%
ethanol purchased from Changsha Tianshun Chemical
Co., Ltd (Hunan, China) at 70°C for 2 h (twice). The
extract was subjected to macroporous resin supplied by
Haiguang Chemical Industrial Company (Tianjin, China)
and eluted with 80% ethanol after treatment with pure
water as the eluent. The eluent was freeze-dried to powder
and stored at 4°C. The lignans content in Eucommia lig-
nans was 71%, as determined by spectrophotometry on a
Beckman Coulter DU 640 spectrophotometer (Beckman
Coulter, Inc. USA) at 277 nm, with pinoresinoldigluco-
side used as the control which was supplied by college
of chemistry and chemical engineering in Central South
University (Hunan, China).
Cell culture
RMCs (HBZY-1 cells) were purchased from China Center
for Type Culture Collection (Wuhan, China). After recov-
ery, RMCs were cultured in RPMI-1640 medium supple-
mented with 10% NCS at 37°C in a humidified atmosphere
of 5% CO2 in air.
MTT assay
RMCs were added into the wells of a 96-well plate at a
density of 3000 cells per well and cultured in RPMI-1640
medium containing 10% NCS. All incubations were per-
formed in RPMI-1640 containing 1% NCS when they
grew to 60% confluence. The study included two parts: (1)
Control group, Eucommia lignans groups (10, 20, 30, 40,
50, 60, 70, 80, or 90 mg/L Eucommia lignans); and (2)
Control group, Ang II group (10 nM Ang II), Losartan
group (10 nM Ang II with 20 μM Losartan), Eucommia
lignans groups (10 nM Ang II with 20, 40 and 80 mg/L
Eucommia lignans). After 48 h, the viability of RMCs was
measuredby MTT method. Then, 20 μL cell Titer 96®
Aqueous One Solution Reagent was added to the medium
in each well, and the absorbance of solubilized blue forma-
zan was recorded by a microplate reader (Molecular
Devices, Spectra MAX. 250, USA) at 490 nm after 1 h
at 37°C in a humidified 5% CO2 atmosphere.
Reverse transcription real-time quantitative PCR
(RT-qPCR) assay
RMCs were assigned to six groups: Control group, Ang
II group (10 nM Ang II), Losartan group (10 nM Ang II
with 20 μM Losartan), and Eucommia lignans groups
(10 nM Ang II with 20, 40 or 80 mg/L Eucommia lignans),
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containing 10% NCS for 48 h. Total RNA from RMCs was
extracted by Trizol® reagent (Invitrogen, Carlsbad, CA,
USA) and the concentration was determined by spectro-
photometry at 260 and 280 nm. A reverted aid cDNA
synthesis kit was used to perform the synthesis of first
strand cDNA from total RNA templates. Real-time qPCR
was performed by Platinum® SYBR® Green qPCR Super
Mix-UDG following the manufacturer’s instructions. The
gene-specific primers are listed in Table 1. The data were
quantitatively analyzed by Stratagene Mx3000p Real-time
PCR (Santa Clara, CA, USA). The glyceraldehyde phos-
phate dehydrogenase (GAPDH) gene was used as the in-
ternal control.
Western blotting
Total protein was extracted from RMCs with radio immu-
noprecipitation assay lysis buffer consisting of 10 mM so-
dium phosphate (pH 7–8), 150 mM NaCl, 0.1% SDS, 0.5%
sodium deoxycholate and 1% Triton X 100 after a 48-h
culture under the conditions described above, and the
protein concentration was determined using a bicinchoni-
nic acid assay kit (Sigma-Aldrich, USA). A total of 40 μg
of total protein was separated on a 10% sodium dodecyl
sulfate polyacrylamide gel (Invitrogen, Carlsbad, CA, USA)
and transferred onto a polyvinylidenefluoride membrane
(Millipore, USA). The membrane was blocked with 5%
skim milk solution in 0.1% tris-buffered saline Tween-20
(TBST) (Shanghai Bioscience Co. Ltd, China) over night.
Subsequently, one of the primary antibodies (rabbit poly-
clonal for Col I, mouse monoclonal [FH-7A] for Col III,
rabbit polyclonal for Col IV, mouse monoclonal [IST-9]
for fibronectin, goat polyclonal for AR, and rabbit poly-
clonal for GAPDH) was added for hybridization before be-
ing incubated with the specific secondary antibody after
washing membranes with TBST (Shanghai Bioscience Co.
Ltd, China) three times. Protein bands were determinedTable 1 Information on the primers used for real-time PCR
Gene Primers Product size (bp)
AR F: TCCCAGGATCAAGGAAATTG 202
R: ACAACAGGAACTGGAGGGTG
FN F: AACGGCCCTGGTTTGTACC 285
R: CTCCAACATATAGCCACCAGTC
Col I F: GAGAGAGCATGACCGATGGA 251
R: CGTGCTGTAGGTGAATCGAC
Col III F: GGCTGCACTAAACACACTGG 229
R: TGGTTGACGAGATTAAAGCAAG
Col IV F: TGTCAGCAATTAGGCAGGTC 205
R: CACCATGTTTCGGAATGGTT
GAPDH F: CAAGTTCAACGGCACAGTCAAG 123
R: ACATACTCAGCACCAGCATCACby the enhanced chemiluminescence western blotting de-
tection system. GAPDH was used as an internal standard
for data normalization.Statistical analysis
Data were shown as mean ± standard deviation (SD) and
were analyzed with SPSS 17.0 software (SPSS Inc., USA).
A P value less than 0.05 was considered statistically sig-
nificant. Significant differences between multiple groups
were analyzed by one-way analysis of variance (ANOVA)
followed by a Dunnett’s post-hoc test.Results
Effects of Eucommia lignans on RMC growth
In comparison with the control, there was no significant
change in the number of cells treated with Eucommia lig-
nans in the 10, 20, 30, 40, 50, 60, 70 and 80 mg/L groups
(P = 0.983, 0.986, 1.000, 0.900, 0.920, 0.515, 0.515, and
0.249, respectively). However, cellular viability decreased
markedly in the group incubated with 90 mg/L Eucommia
lignans (P = 0.001) (Figure 1). Therefore, the incubated con-
centrations of Eucommia lignans for the following experi-
ments were 20, 40 and 80 mg/L.Inhibition of Eucommia lignans on Ang II-induced
RMC proliferation
The Ang II receptor blocker, losartan (20 μM), signifi-
cantly decreased the proliferation of RMCs induced by
Ang II (P = 0.004). The inhibitory effects were also ob-
served in the different Eucommia lignans-treated groups
(P = 0.034, P < 0.001, and P < 0.001) (Figure 2).Figure 1 Effects of Eucommia lignans on RMCs growth. RMCs
were treated with various concentrations of Eucommia lignans (10,
20, 30, 40, 50, 60, 70, 80, or 90 mg/L) for 48 h, and cell viability was
assessed by MTT method. Results were given in mean ± SD (n = 6).
##P < 0.01 vs. the control group.
Figure 2 Inhibitory effects of Eucommia lignans on Ang II-induced
RMCs proliferation. All values represented mean ± SD (n = 6). Los:
losartan; Lig: lignans. #P< 0.05 vs. the control group, *P< 0.05, **P< 0.01
vs. Ang II group.
Figure 3 Inhibitory effects of Eucommia lignans on Ang
II-induced ECM biosynthesis in RMCs. (A) depression of
Eucommia lignans on Ang II-increased mRNA expression levels; (B)
inhibition of Eucommia lignans on Ang II-stimulated protein expression
levels. RT-qPCR and western blot was used to detect the mRNA and
protein expressions separately. GAPDH was used as an internal loading
control gene. Both mRNA and protein relative expression levels were
expressed as folds of control. All values were expressed as mean ± SD
(n = 3). Los: losartan; Lig: lignans. ##P < 0.01 vs. the control group,
**P < 0.01 vs. Ang II group.
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biosynthesis in RMCs
The changes in Col I, Col III, Col IV and fibronectin
production are shown in Figure 3. mRNA and protein
expression increased with Ang II stimulation. All of the
increased expression levels induced by Ang II could be
attenuated by losartan treatment (Col IV mRNA, P =
0.007; others, P < 0.001). Furthermore, Eucommia lignans
also significantly diminished their ascended expression
(Col I protein of 20 mg/L, P = 0.001; Col I protein of
40 mg/L, P = 0.002; Col IV mRNA of 80 mg/L, P = 0.031;
others, P < 0.001), although decreases of the Col IV mRNA
level of the low and middle concentration lignans groups
did not reach a statistically significant difference (P = 0.084
and P = 0.134). Eucommia lignans could suppress Ang II-
stimulated biosynthesis of ECM in RMCs (Figure 3B).
Block of Eucommia lignans on Ang II-induced AR
expression in RMCs
The mechanisms of Eucommia lignans inhibitory effects
were tentatively elucidated from data of our previous
animal experiments [22]. Both mRNA and protein ex-
pression of AR were effectively enhanced by Ang II (P <
0.001) (Figure 4). Losartan and Eucommia lignans clearly
attenuated all expression stimulated by Ang II (Losartan,
P = 0.045; 20 mg/L Lignans, P = 0.01; others, P < 0.001).
The experiment demonstrated that Eucommia lignans
could suppress Ang II-induced AR expression in RMCs.
Discussion
Eucommia lignans (10 to 90 mg/L) was incubated with
RMCs, according to our previous study with renal tubular
epithelial cells (HK-2 cells) [12]. Eucommia lignans at
90 mg/L affected the normal growth of RMCs. Therefore,Eucommia lignans amounts in the subsequent experi-
ments were set as 20, 40 and 80 mg/L.
The result consistent with those previous reports on the
pathogenesis of hypertensive glomerulosclerosis [3,5], and
Figure 4 Inhibitory effects of Eucommia lignans on Ang
II-induced AR expression in RMCs. (A) Inhibition of Eucommia
lignans on Ang II-increased AR mRNA levels; (B and C) depression
of Eucommia lignans on Ang II-stimulated AR protein expression.
Cells were incubated as described in Methods. RT-qPCRand Western
blotting was used to detect the mRNA and protein expressions. GAPDH
was selected as an internal standard gene. AR relative expression levels
were indicated as folds of control. All results were shown in mean ± SD
(n = 3). Los: losartan; Lig: lignans. ##P< 0.01 vs. the control group,
**P< 0.01 vs. Ang II group.
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cluding mainly Col IV, fibronectin, Col I and Col III in
in vivo or in vitro [4,23-28]. Our present study found that
Ang II (10 nM) stimulated proliferation and production of
Col IV, fibronectin and Col I in RMCs, and that bothmRNA and protein of Col III were over-expressed in
RMCs induced by Ang II.
In the current study, Ang II-induced RMC prolifera-
tion was significantly inhibited by Eucommia lignans,
and there was a reduction in the raised expression of
Col I, Col III, Col IV and fibronectin at both mRNA and
protein levels. However, the mechanisms of Eucommia
lignans in preventing Ang II-induced proliferation of RMC
and production of ECM are poorly defined. According to
some reports, AR, as a member of the aldo-ketoreductase
superfamily, is involved in the cellular proliferation and
ECM (Col I, Col IV and fibronectin) production induced
by TGF-β1 or PDGF in human or rat MCs, and TGF-β1
and PDGF are downstream genes of Ang II [13-16]. There-
fore, we tested the hypothesis that AR might participate in
the pathological process in RMCs induced by Ang-II. This
study demonstrated both AR mRNA and protein levels in-
crease in RMCs were induced by Ang-II, in addition to our
previous finding that Eucommia lignans decreased the pro-
duction of Col III by degrading the expression of AR pro-
tein in SHR renal tissue [12], showed that the Eucommia
lignans’ effects on Ang II-induced pathological changes in
RMCs involved the reduction in the expression of AR. Our
further studies will examine the signal pathways for the re-
duction of Eucommia lignans by AR expression.
Conclusions
Eucommia lignans (Du-zhong) inhibited Ang II-stimulated
extracellular matrix biosynthesis in mesangial cells.
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